COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,390 Articles (22,816 medRxiv, 8,574 bioRxiv)

Most recent first Previous |  Page 1369: Articles 13681-13690  | Next

The infinite alleles model revisited: a Gibbs sampling approach
Manceau, M.
10.1101/2021.07.21.452479 — Posted: 2021-07-22
Impact of human airway epithelial cellular composition on SARS-CoV-2 infection biology
Wang, Y., Thaler, M., Ninaber, D., van der Does, A. M., S. Ogando, N. S., Beckert, H., Taube, C., Salgado Benvindo Da Silva, C., Snijder, E. J., Bredenbeek, P. J., Hiemstra, P., van Hemert, M. J.
10.1101/2021.07.21.453304 — Posted: 2021-07-22
Longitudinal analysis of antibody responses to the Pfizer BNT162b2 vaccine in Patients Undergoing Maintenance Hemodialysis
Weigert, A., Bergman, M.-L., Goncalves, L., Godinho, I., Duarte, N., Abrantes, R., Borges, P., Brennand, A., Malheiro, V., Matoso, P., Akpogheneta, O., Kosack, L., Cruz, P., Nogueira, E., Pereira, M., Ferreira, A., Marques, M., Nunes, T., Viana, J., Demengeot, J., Penha-Goncalves, C.
10.1101/2021.07.20.21260849 — Posted: 2021-07-22
The effect of singers masks on the impulse dispersion of aerosols during singing
Echternach, M., Hermann, L. A., Gantner, S., Tur, B., Peters, G., Westphalen, C., Benthaus, T., Koeberlein, M. C., Kuranova, L., Doellinger, M., Kniesburges, S.
10.1101/2021.07.20.21260853 — Posted: 2021-07-22
Workplace risk management for SARS-CoV-2: a three-step early in-tervention strategy for effective containment of infection chains with special regards to virus variants with increased infectivity
Paassen, A., Anderle, L., John, K., Wilbrand, S.
10.1101/2021.07.21.21260756 — Posted: 2021-07-22
Disentangling post-vaccination symptoms from early COVID-19
Canas, L. S., Osterdahl, M. F., Deng, J., Hu, C., Selvachandran, S., Polidori, L., May, A., Molteni, E., Murray, B., Chen, L., Kerfoot, E., Klaser, K., Antonelli, M., Hammers, A., Spector, T., Ourselin, S., Steves, C. J., Sudre, C. H., Modat, M., Duncan, E. L.
10.1101/2021.07.21.21260906 — Posted: 2021-07-22
Concentration of SARS-CoV-2 from large volumes of raw wastewater is enhanced with the inuvai R180 system
Monteiro, S., Rente, D., Cunha, M. V., Marques, T., Cardoso, E., Alvaro, P., Vilaca, J., Ribeiro, J., Silva, M., Coelho, N., Broco, N., Carvalho, M., Santos, R.
10.1101/2021.07.21.21260907 — Posted: 2021-07-22
A Wastewater-based Epidemiology tool for COVID-19 Surveillance in Portugal
Monteiro, S., Rente, D., Cunha, M. V., Gomes, M. C., Marques, T., Lourenco, A., Cardoso, E., Alvaro, P., Silva, M., Coelho, N., Vilaca, J., Meireles, F., Broco, N., Carvalho, M., Santos, R.
10.1101/2021.07.21.21260905 — Posted: 2021-07-22
Spread of infection and treatment interruption among Japanese workers during the COVID-19 pandemic: a cross-sectional study
Akashi, J., HIno, A., Tateishi, S., Nagata, T., Tsuji, M., Ogami, A., Matsuda, S., Kataoka, M., Fujino, Y.
10.1101/2021.07.21.21260691 — Posted: 2021-07-22
SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: an in-silico proof-of-principle of proteomics-based drug repurposing
Latosinska, A., Siwy, J., Cherney, D. Z., Perkins, B. A., Mischak, H., Beige, J.
10.1101/2021.07.21.21260351 — Posted: 2021-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).